Preview

Новый принцип лечения сахарного диабета 2-го типа путем стимуляции глюкозурии

https://doi.org/10.14341/probl201258454-57

Аннотация

Представлены данные клинических и экспериментальных исследований новой группы препаратов - ингибиторов системы натрий-глюкозного котранспортера SGLT2, предложенных для лечения сахарного диабета 2-го типа. Механизм действия ингибиторов SGLT2 заключается в стимуляции глюкозурии и последующего снижения гипергликемии. Эта новая группа медикаментозных средств отличается эффективностью, безопасностью, ограниченным спектром побочных эффектов. Среди последних существенны инфекционные поражения мочевыводящих путей и генитальных органов.

Об авторе

V Shvarts



Список литературы

1. Bakris G.L., Fonseca V.A., Sharma K., Wright E.M. Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Kidney Int 2009; 75: 1272-1277.

2. Zelikovic I. Aminoaciduria and glycosuria. In: Pediatric Nephrology. Eds. E.D. Avner, W.E. Harmon, P. Niaudet. 5th edition. Philadelphia: Lippincott Williams & Wilkins 2004; 701-728.

3. Moe O.W., Wright S.H., Palacín M. Renal handling of organic solutes. In: Brenner and Rector's The Kidney. Ed. B.M. Brenner. 8th edition. Philadelphia: Saunders Elsevier 2008; 214-247.

4. Hediger M.A., Coady M.J., Ikeda T.S., Wright E.M. Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature 1987; 330: 379-381.

5. Wright E.M., Hirayama B.A., Loo D.F. Active sugar transport in health and disease. J Intern Med 2007; 261: 32-43.

6. Ehrenkranz R.R.L., Lewis N.G., Kahn C.R., Roth J. Phlorizin: a review. Diabet Metab Res Rev 2005; 21: 31-38.

7. Washburn W.N. Evolution of sodium glucose cotransporter 2 inhibitors as anti-diabetic agents. Exp Opin Ther Patents 2009; 19: 1485-1499.

8. Fujimoto Y., Torres T.P., Donahue E.P., Shiota M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 2006; 55: 2479-2490.

9. Abdul-Ghani M.A., Norton L., Defronzo R.A. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes. Endocrinol Rev 2011; 32: 4: 515-531.

10. Washburn W.N. Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2. J Med Chem 2009; 52: 1785-1794.

11. Bailey C.J., Gross J.L., Pieters A., Bastien A., List J. Effect of dapagliflozin in patienzs with type 2 diabetes who have inadequate glyceamic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 375: 2223-2233.

12. Nauck M.A., Del Prato S., Meier J.J., Durán-García S., Rohwedder K., Elze M., Parikh S.J. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequete glyceamic control with metformin: a randomised, 52-week, double-blind, active-controlled noninferiority trial. Diabetes Care 2011; 34: 2015-2022.

13. Kasichayanula S., Liu X., Shyu W.C., Zhang W., Pfister M., Griffen S.G., Li T., LaGreta F.P., Boulton D.W. Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimeperide or sitagliptin in healthy subjects. Diabetes Obes Metab 2011; 13: 47-54.

14. Zhang L., Feng Y., List J., Pfister M., Ng C.M. Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effect on glycaemic control and body weight. Diabetes Obes Metab 2010; 12: 510-516.

15. Komoroski B., Vachharajani N., Feng Y., Li L., Kornhauser D., Pfister M. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus. Clin Pharm Ther 2009; 85: 513-519.

16. Ng C.M., Zhang L., List J., Pfister M. Mechanismbased disease model to describe the plasma/urine glucose-time profiles in placebo-or dapagliflozin-treated normal and type 2 diabetes mellitus (T2DM) subjects. Clin Pharm Ther 2010; 87: Suppl 1: S17-S18.


Для цитирования:


. Новый принцип лечения сахарного диабета 2-го типа путем стимуляции глюкозурии. Проблемы Эндокринологии. 2012;58(4):54-57. https://doi.org/10.14341/probl201258454-57

For citation:


Shvarts V.I. A new principle of the treatment of type 2 diabetes mellitus by stimulation of glucosuria. Problems of Endocrinology. 2012;58(4):54-57. (In Russ.) https://doi.org/10.14341/probl201258454-57

Просмотров: 49


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)